CEVA: this is a timely investment for healthcare logistics
CEVA Logistics has opened its temperature-controlled airfreight station today adjacent to Singapore’s Changi International Airport.
CEVA’s latest cold station lies within the Free Trade Zone of the Airport Logistics Park of Singapore, facilitating seamless regional distribution in the Association of Southeast Asian Nations (ASEAN) region and providing in-transit storage, value-add services and quick turnaround times for connecting to global markets.
To meet the demands of healthcare and pharmaceutical customers, the new station is composed of two distinct areas dedicated to temperature management of shipments within the ranges of 15 to 25 degrees Celsius and 2 to 8 degrees Celsius. CEVA will continue to focus on the spectrum of products requiring a range of 2 to 8 degrees Celsius, including certain COVID-19 vaccines, although the company provides solutions for other products, including vaccines requiring lower temperatures throughout transport.
Elaine Low, managing director for Southeast Asia and Pacific, CEVA Logistics says: “As CEVA’s first airfreight cold chain facility in Singapore, this is a timely investment for healthcare logistics. This air hub is now capable of supporting the regional distribution of vaccines and other pharmaceutical supplies that are critically needed in Southeast Asia at the moment. In addition, our healthcare customers will benefit from the range of value-added services, such as dry ice, relabelling and cross-stocking within the free trade zone.”
Niels van Namen, executive vice president of global healthcare, CEVA Logistics comments: “Our FORPATIENTS commitment is driving our investment in healthcare logistics. These airfreight cold chain stations are just one more example of how we put the patient first, even in the supply chain. We have the expertise and now another facility to continue supporting customers who require stringent temperature management within their global supply chains to ensure the integrity of their patients’ products.”
